Macro Group Pharmaceuticals (Macro Capital)E Balans Gezondheid
Financiële gezondheid criteriumcontroles 1/6
Macro Group Pharmaceuticals (Macro Capital)E has a total shareholder equity of EGP27.4M and total debt of EGP243.8M, which brings its debt-to-equity ratio to 891.5%. Its total assets and total liabilities are EGP517.5M and EGP490.1M respectively.
Belangrijke informatie
891.5%
Verhouding schuld/eigen vermogen
ج.م243.82m
Schuld
| Rente dekkingsratio | n/a |
| Contant | ج.م107.28m |
| Aandelen | ج.م27.35m |
| Totaal verplichtingen | ج.م490.14m |
| Totaal activa | ج.م517.49m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: MCRO's short term assets (EGP415.3M) do not cover its short term liabilities (EGP457.3M).
Langlopende schulden: MCRO's short term assets (EGP415.3M) exceed its long term liabilities (EGP32.9M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: MCRO's net debt to equity ratio (499.2%) is considered high.
Schuld verminderen: Insufficient data to determine if MCRO's debt to equity ratio has reduced over the past 5 years.
Schuldendekking: MCRO's operating cash flow is negative, therefore debt is not well covered.
Rentedekking: Insufficient data to determine if MCRO's interest payments on its debt are well covered by EBIT.